Volume 65, Issue 3 pp. 303-310
CLINICAL RESEARCH ARTICLE

Pilot study of a novel transmembranous electromyography device for assessment of oral cavity and oropharyngeal muscles

Deepak Menon MD, DM

Deepak Menon MD, DM

Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Ontario, Canada

Search for more papers by this author
Perry Mansfield MD

Perry Mansfield MD

Division of Otolaryngology – Head and Neck Surgery, Senta Clinic, San Diego, California, USA

Search for more papers by this author
Derrick Cordice BS

Derrick Cordice BS

Division of Otolaryngology – Head and Neck Surgery, Senta Clinic, San Diego, California, USA

Search for more papers by this author
Chris Studer BS

Chris Studer BS

Powell Mansfield, Inc, San Diego, California, USA

Search for more papers by this author
Michael O'Leary MD

Michael O'Leary MD

Division of Otolaryngology – Head and Neck Surgery, Senta Clinic, San Diego, California, USA

Search for more papers by this author
Geoffrey Sheean MD

Geoffrey Sheean MD

Powell Mansfield, Inc, San Diego, California, USA

Search for more papers by this author
Vera Bril MD, FRCP(C)

Corresponding Author

Vera Bril MD, FRCP(C)

Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, Toronto, Ontario, Canada

Correspondence

Vera Bril, Ellen & Martin Prosserman Centre for Neuromuscular Diseases, University Health Network, University of Toronto, 5EC-309, 200 Elizabeth Street, Toronto, ON M5G 2C4, Canada.

Email: [email protected]

Search for more papers by this author
First published: 24 December 2021
Citations: 2

Funding information: Powell Mansfield Inc.

Abstract

Introduction/Aims

Electromyography (EMG) can provide valuable insights into the pathophysiology of oropharyngeal muscles in various disease states, but the invasive nature of the conventional needle EMG (nEMG) has its limitations in this setting. We aimed to examine the inter-rater reliability (IRR) of a novel transmembranous EMG (tmEMG) sensor as a non-invasive technique for assessment of oral cavity and oropharyngeal muscles for neuromuscular pathology.

Methods

The study was a prospective, cohort, pilot study with blinded data analysis in healthy participants (n = 6), patients with moderate to severe obstructive sleep apnea (OSA) (n = 5) and bulbar amyotrophic lateral sclerosis (ALS) (n = 5). Each patient underwent sampling from bilateral palatoglossus (PG) and genioglossus (GG), using both tmEMG and nEMG. IRR was expressed as percentage agreement and prevalence-adjusted bias-adjusted kappa coefficient (PABAK).

Results

Substantial IRR was found for participants with ALS (81.6%, PABAK 0.63) and OSA (78.8%, PABAK 0.61), and in healthy participants (87.1%, PABAK 0.74). A better IRR was seen with tmEMG (95.7%, PABAK 0.92) than with nEMG (73.9%, PABAK 0.48) for healthy participants and also for those with OSA. Studies from GG had higher IRR than PG. Only one participant had a minor adverse event (sore throat).

Discussion

The current study shows that analysis of PG and GG in both healthy and disease states using tmEMG has high IRR compared with nEMG analysis. Further validation studies can be undertaken to test its utility in analysis of oral cavity and oropharyngeal muscles.

CONFLICTS OF INTEREST

Dr. Mansfield, Dr. Bril, and Mr. Studer have equity ownership in Powell Mansfield, Inc. Dr. Sheean, Dr. O'Leary, and Mr. Cordice serve or have served as consultants to Powell Mansfield, Inc.

DATA AVAILABILITY STATEMENT

The data that support the findings of this study are available from the corresponding author upon reasonable request

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me